Treating stroke in the 21st century.
Roxana Oprisiu, Jean-Marie Serot, Sandra E Black, Jean-Michel Achard, Albert Fournier
No abstract text available.
Angiotensin II Type 1 Receptor Blockers
Benzimidazoles
Biphenyl Compounds
Erythropoietin
Humans
Randomized Controlled Trials as Topic
Stroke
Tetrazoles
Angiotensin II Type 1 Receptor Blockers
Benzimidazoles
Biphenyl Compounds
Tetrazoles
Erythropoietin
candesartan
